Insider · CIK 0001725663
Kory James Wentworth
Files at TRDA (Entrada Therapeutics, Inc.). First filing Nov 13, 2024, latest Nov 24, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TRDA: Entrada Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Entrada Therapeutics, Inc. | $89k 8,910 shares | -7% | +101% from low-53% from high | |
| 2Weak | Entrada Therapeutics, Inc. | $19k 1,784 shares | -2% | - | |
| 12Weak | Entrada Therapeutics, Inc. | $120k 6,000 shares | -8% | - | |
| 11Weak | Entrada Therapeutics, Inc. | $173k 8,637 shares | -10% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | TRDA Entrada Therapeutics, Inc. | FTax withholding Common Stock | -1,733 | $7.14 | $12k | 117,277 | 39 d ago |
| Nov 21, 2025 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,910 | $9.98 | $89k | 110,026 | Nov 24, 2025 |
| Sep 2, 2025 | TRDA Entrada Therapeutics, Inc. | FTax withholding Common Stock | -1,734 | $5.43 | $9,416 | 118,936 | Sep 4, 2025 |
| Apr 3, 2025 | TRDA Entrada Therapeutics, Inc. | MOption exercise Common Stock | +11,134 | $2.10 | $23k | 120,670 | Apr 4, 2025 |
| Apr 3, 2025 | TRDA Entrada Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -11,134 | $0.00 | $0 | 20,023 | Apr 4, 2025 |
| Mar 17, 2025 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,784 | $10.67 | $19k | 109,536 | Mar 19, 2025 |
| Mar 1, 2025 | TRDA Entrada Therapeutics, Inc. | AGrant or award Common Stock | +42,400 | $0.00 | $0 | 116,249 | Mar 4, 2025 |
| Mar 3, 2025 | TRDA Entrada Therapeutics, Inc. | FTax withholding Common Stock | -4,929 | $11.68 | $58k | 111,320 | Mar 4, 2025 |
| Mar 1, 2025 | TRDA Entrada Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +63,300 | $0.00 | $0 | 63,300 | Mar 4, 2025 |
| Nov 29, 2024 | TRDA Entrada Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $2.10 | $2,100 | 74,849 | Dec 3, 2024 |
| Nov 29, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $19.97 | $20k | 73,849 | Dec 3, 2024 |
| Dec 2, 2024 | TRDA Entrada Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | $2.10 | $11k | 78,849 | Dec 3, 2024 |
| Dec 2, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $20.00 | $100k | 73,849 | Dec 3, 2024 |
| Nov 29, 2024 | TRDA Entrada Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 36,157 | Dec 3, 2024 |
| Dec 2, 2024 | TRDA Entrada Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 31,157 | Dec 3, 2024 |
| Nov 11, 2024 | TRDA Entrada Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,000 | $2.10 | $13k | 82,486 | Nov 13, 2024 |
| Nov 11, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,637 | $19.98 | $173k | 73,849 | Nov 13, 2024 |
| Nov 11, 2024 | TRDA Entrada Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 37,157 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.